ACCELERATE NAMs ADOPTION
The New Approach Methodology Business Expert Group NAMBEG is a global think tank of independent life sciences business consultants.
With the common goal of advancing the adoption of New Approach Methodologies (NAMs), we serve as a central link between industry stakeholders and decision makers.
We combine our scientific and business expertises in the NAMs industry to provide clear perspective on the opportunities and challenges these technologies presents. NAMBEG supports the adoption of NAMs in applications where they may offer added value over traditional methods.
NAMs. Strong Promise, Real Barriers
New Approach Methodologies (NAMs) are alternatives to animal experimentation used for the assessment of toxicity, efficacy, pharmacology, and potential risks of drugs and chemicals. They include technologies such as organ-on-chip systems, 3D cell culture, artificial intelligence algorithms, and in silico modelling. NAMs may improve the prediction of clinical trial outcomes, thereby reducing development risks and accelerating the delivery of safe and effective therapies.
However, several hurdles still stand in the way of broader NAMs market adoption:
-
Validation, including demonstrated predictive superiority compared to state-of-the-art models
-
Standardize protocols, readouts, and quality criteria to improve reproducibility across fragmented markets and regulatory pathways in North America, Europe, and Asia
-
Partial lack of Context of Use-driven development strategy
-
Technological inertia
The NAMs market
>420
NAMs-developping companies worldwide
$812M
NAMs global market size worldwide
8.9%
Expected CAGR
Investors
• Comprehensive understanding of investment opportunities
• Funding landscape
• Market forecasts
Non-Profit Organizations
• Information about the potential of NAMs
• Forecast of the commercial applications and impacts of NAMs
Capabilities
We support a broad range of industry stackeholders
Policy Makers
• Market status
• Perception of regulations by private stackeholders
• Funding needs
Biopharma & Chemicals Companies
• Product / offer positioning versus NAMs
• Risks & opportunity assessment
• Technology & market forecasts
Investors
Comprehensive understanding of investment opportunities
Funding landscape
Market forecasts
NAMs Developpers
Guidance for go-to-market strategy
Support business development strategy & execution
Identification of market gaps & opportunities
NAM Developpers
• Guidance for go-to-market strategy
• Support of business development strategy & execution
• Identification of market gaps & opportunities
Research Consortia
• Guidance of market fit & technology standardization
• Identification of market needs
Independent Expertise, One Shared Ambition
NAMBEG, the NAMs Business Expert Group, was formed as an independent, international group of business experts to help moving the NAM industry beyond those thresholds. We aim to make proven business and technology models visible to decision makers, to present NAM capabilities in terms of Context of Use, and to bring the commercial perspective into validation and standardization efforts.
With over 40 years of combined business development experience in the NAMs industry, NAMBEG advises and connects with a broad network of stakeholders.